Clinical Trial: Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07591012) titled 'Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease' on April 13.

Brief Summary: The goal of this clinical trial is to learn if a dietary supplement called ButyMixx can help people with ulcerative colitis in remission feel better and keep their intestines less inflamed.

ButyMixx contains:

* Sodium butyrate, a substance normally produced by our gut microbiota that helps protect the intestinal lining and reduce inflammation.

* A "beneficial" yeast (Kluyveromyces marxianus), similar to probiotics, which may support the balance of the intestinal microbiota.

It will also learn about the safety of ...